Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.
Davies C, Segre G, Estradé A, Radua J, De Micheli A, Provenzani U, Oliver D, Salazar de Pablo G, Ramella-Cravaro V, Besozzi M, Dazzan P, Miele M, Caputo G, Spallarossa C, Crossland G, Ilyas A, Spada G, Politi P, Murray RM, McGuire P, Fusar-Poli P.
Lancet Psychiatry. 2020 May;7(5):399-410. doi: 10.1016/S2215-0366(20)30057-2. Epub 2020 Mar 24.
Methylene Blue in the Treatment of Neuropsychiatric Disorders.
Alda M.
CNS Drugs. 2019 Aug;33(8):719-725. doi: 10.1007/s40263-019-00641-3.
Bright light therapy.
Prasko J.
Neuro Endocrinol Lett. 2008 Nov;29 Suppl 1:33-64.
Geriatric mania.
Young RC.
Clin Geriatr Med. 1992 May;8(2):387-99.
[Organic mixed affective disorder].
Sasaki M.
Ryoikibetsu Shokogun Shirizu. 2003;(40):180-3.
Cognitive dysfunction in schizophrenia, affective disorder and organic brain disease.
Abrams R, Redfield J, Taylor MA.
Br J Psychiatry. 1981 Sep;139:190-4. doi: 10.1192/bjp.139.3.190.
Causes of organic mood disorder.
Rundell JR, Wise MG.
J Neuropsychiatry Clin Neurosci. 1989 Fall;1(4):398-400. doi: 10.1176/jnp.1.4.398.
Developmental Issues and Mental Health.
Bonham E.
Nurs Clin North Am. 2019 Dec;54(4):585-593. doi: 10.1016/j.cnur.2019.08.003. Epub 2019 Oct 9.
Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study.
Chen CK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, Ouyang WC, Javed A, Khan MNS, Grover S, Avasthi A, Kallivayalil RA, Chee KY, Chemi N, Kato TA, Hayakawa K, Pariwatcharakul P, Maramis M, Seneviratne L, Sim K, Tang WK, Oo T, Sartorius N, Tan CH, Chong MY, Park YC, Shinfuku N, Lin SK.
Asian J Psychiatr. 2023 Jul;85:103613. doi: 10.1016/j.ajp.2023.103613. Epub 2023 Apr 28.
Organic affective disorder in a patient with congenital adrenal hyperplasia.
Feldman SR, Krishnan KR, McPherson H, Meglin DE.
Biol Psychiatry. 1987 Jun;22(6):767-70. doi: 10.1016/0006-3223(87)90209-5.
